Laser vaporization of the prostate KRN 633 KRN633 and holmium laser ablation / enucleation of the prostate, h More often be reduced with Hnlichen results as TURP and complications. Open surgery for LUTS secondary R to patients with BPH is a very big s prostate gland or that symptomatic comorbidities such as bladder stones Or big bladder diverticulum e symptomatic reserved. The Sidney Kimmel Center for Prostate and Urologic. Dr. Sandhu has been in meetings that are attended by American Medical Systems, Inc. has benign prostatic hyperplasia, BPH, or more than 50% of the men and 50 Older and nearly 90% of the men at the age of 80, 1 Pr prevalence of BPH is expected cro be entered, because Bev lkerung of M nnern at the age of 65 years went from 17 million to almost 30 million 2 in 2000 to around 4.
5 million visits to doctors’ offices Prim rdiagnose of BPH and almost 8 million doctor visits Born a primary re or secondary re diagnosis of an enlarged BPH.3 Erte prostate is a heavy burden on Besch ftigte and their employers for co ts for direct medical and lost JTC-801 Opioid receptor antagonists and agonists work time.4 Co ts direct and indirect private sector related to BPH with 3.9 billion.4 but shops are being protected are few data on differences in the collaboration ts associated with various therapies for BPH. Current treatment options for BPH go Ren watchful waiting, drug Se treatment, minimally invasive procedures and prostate surgery.5 is in most cases Cases the treatment of first choice of pharmacological treatment with alpha-blockers or inhibitors of 5-alpha- reductase.
Alpha-blockers to treat symptoms of BPH by relaxing the smooth muscle of the prostate and bladder neck so that urine flowing better S. Thanks to their mechanism of action to achieve these drugs PI-103 relatively rapid improvement in symptoms of lower urinary tract, but have no effect on prostate growth.6 In contrast, five IRA inhibits the production of dihydrotestosterone, the main cause of prostate growth, making the size e of the prostate. 7.8 So, five IRA directly affect the progression of prostate disease and its clinical sequelae. However, the kind caused by four to six months delay in your processing from the beginning of therapy 5 IRA to a significant shrinkage of the prostate one Similar delay Storage at the relief of lower urinary tract symptoms.
7, 8 Given the need for improvements in symptoms and the Simultaneous are progression of the disease there is a trend towards the use of combination therapy or sequential therapy with alpha-blockers and 5 IRA. Treatment with combination benefits from the rapid improvement of symptoms From my alpha-blockers and the potential disease made by the five IRA offered. Two studies have examined the clinical utility of a drug Sen combination therapy showed the symptoms My prostate and the combination of Avodart and 11 In addition Tamsulosin.9 best Preferential con a database retrospective analysis of the clinical benefits of Early or late Ended using a 5-ARI therapy with alpha-blocker therapy. 12 support to more than these basic analysis of historical data, our study evaluated the effects of early versus zinc Siege to the start of the 5 ARI therapy, treatment with alpha-blockers, which exist on the clinical progression, acute urinary retention , And the results of prostate surgery in connection with another populatio